- EMA: CHMP adopted a positive opinion for Ocrevus (ocrelizumab) 300-mg c ... read more
- EMA: CHMP adopted a positive opinion for Intrarosa (prasterone) 6.5 mg ... read more
- EMA: CHMP adopted a positive opinion for Fasenra (benralizumab) 30-mg s ... read more
- MoH: Draft of Government` Emergency Ordinance amending and supplementi ... read more
- MoH: Draft Order amending and supplementing Annex 1 to the MoH Order 25 ... read more
- MoH: Call for tender - Competitive national tender for the acquisition ... read more
- MoH: Order 871/1.300/104/2017 for amending Annexes 1 and 2 of the Order ... read more
- MoH: Order 1.203 of October 16, 2017 to amend the MoH Order 2.071 / 200 ... read more
- MoH: Draft Order amending and completing the MoH Order 914/2006 approvi ... read more
- NMA: For the attention of Pharmacies, Hypermarkets, Supermarkets, Onlin ... read more
- MoH: Draft Order for completing the Order of the Minister of Health 449 ... read more
- MoH: Order 1.023 of September 5, 2017 for the approval of the Regulatio ... read more
- MoH : Draft Order for the approval of methodological guidelines for the ... read more
- CASMB: Press Release - Additional funds medical analyzes and high-perfo ... read more
- MoH: Draft Human Transplant Law read more
- MoH: Draft Order for amending and completing the Order no. 1378/2287 of ... read more
- MoH: Draft Decision to amend the methodological norms on cross-border h ... read more
- MoH: Order on composition, attributions, regulation of organization and ... read more
- MoH: Government Decision on information on the amount of health insuran ... read more
- MoH: Government Decision on amending some normative acts related to the ... read more
Trends and developments
Jun
03
2023
-
Government Decision (GD) for updating the organization and functioning of Ministry of Health
GD published in the Official Gazette is updating the personnel and cars numbers within Ministry of Health. -
The highest clawback level recorded in the last quarter of the year
NHIH published the total value of reimbursed medicines in the fourth quarter of 2016. -
HAS has re-issued drugs for Alzheimer disease
HAS has published online, on 25th of January, its new evaluation regarding drugs for Alzheimer’s disease. -
NICE Guidance: Mepolizumab for treating severe refractory eosinophilic asthma
Technology appraisal guidance [TA431], published on 25 January 2017 -
NICE Guidance: Sofosbuvir-velpatasvir for treating chronic hepatitis C
Technology appraisal guidance [TA430], published on 25 January 2017
